EU has new deal with Pfizer for 300 mln more COVID vaccine doses

Fri, 08th Jan 2021 09:02

BRUSSELS, Jan 8 (Reuters) - The head of the European
Commission Ursula von der Leyen said on Friday the EU had
reached a deal with Pfizer and BioNTech for
300 million additional doses of their COVID-19 vaccines,
doubling the amount of doses from these producers.
(Reporting by Francesco Guarascio @fraguarascio)

Related Shares

More News

Today 22:50

US CDC narrows age recommendation for RSV shots in US

June 26 (Reuters) - The U.S. CDC on Wednesday narrowed its recommendation for use of respiratory syncytial virus vaccines in older adults this year ...

Today 11:00

US advisers to consider RSV shots as GSK looks to keep market lead

June 26 (Reuters) - A committee of outside experts to the U.S. CDC are set to vote on whether to expand the age group of adults who should receive r...

25 Jun 2024 08:25

Merck KGaA shares plunge after cancer drug hopeful fails

FRANKFURT, June 25 (Reuters) - Shares in Germany's Merck KGaA slumped 8.9% at the open on Tuesday after the diversified group late on Monday said a ...

24 Jun 2024 08:55

TOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EU

(Alliance News) - GSK PLC on Monday said it has landed an approval in Japan and also highlighted regulatory progress in the EU.

24 Jun 2024 07:43

LONDON BRIEFING: Prudential announces buyback; Frasers and THG in deal

(Alliance News) - London's FTSE 100 is called to open lower at the start of the week, with share price falls for major US tech shares, Nvidia included...